Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and why this meeting is so important in this space. The combination of ...

Detailed results were presented at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco. ...

This study that evaluates an annual injection of a pre-exposure prophylaxis medication for HIV has been published in The Lancet and presented simultaneously at the Conference on Retroviruses and ...

SAN FRANCISCO — During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV survivor, addressed conference attendees and discussed ...

The phase 2 study – reported at the Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado – looked at the combination of MSD’s experimental long-acting reverse ...

researchers said at the Conference on Retroviruses and Opportunistic Infections.

Two clinical trials presented last week at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco show that a two-drug regimen of doravirine / islatravir is ...

based on this latest study presented at the Conference of Retroviruses and Opportunistic Infections. (The study has not yet been published in a peer-reviewed journal.) Researchers studied more ...